These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 10091779)
1. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Fosså SD; Bokemeyer C; Gerl A; Culine S; Jones WG; Mead GM; Germa-Luch JR; Pont J; Schmoll HJ; Tjulandin S Cancer; 1999 Feb; 85(4):988-97. PubMed ID: 10091779 [TBL] [Abstract][Full Text] [Related]
2. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study. Tscherry G; Jacky E; Jost LM; Stahel RA Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168 [TBL] [Abstract][Full Text] [Related]
4. A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system. Allen JC; DaRosso RC; Donahue B; Nirenberg A Cancer; 1994 Aug; 74(3):940-4. PubMed ID: 8039122 [TBL] [Abstract][Full Text] [Related]
5. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204 [TBL] [Abstract][Full Text] [Related]
6. [Cerebral germ cell tumors in adults. A retrospective study of 19 cases]. Agranat P; Jedynak P; Epardeau B; Extra JM; Mignot L Bull Cancer; 1995 Aug; 82(8):650-9. PubMed ID: 7492821 [TBL] [Abstract][Full Text] [Related]
7. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
9. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study. Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477 [TBL] [Abstract][Full Text] [Related]
10. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359 [TBL] [Abstract][Full Text] [Related]
11. The management of brain metastasis in nonseminomatous germ cell tumours. Mahalati K; Bilen CY; Ozen H; Aki FT; Kendi S BJU Int; 1999 Mar; 83(4):457-61. PubMed ID: 10210571 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194 [TBL] [Abstract][Full Text] [Related]
14. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
15. Management of brain metastases from germ cell tumors: a single center experience. Boyle HJ; Jouanneau E; Droz JP; Fléchon A Oncology; 2013; 85(1):21-6. PubMed ID: 23816811 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Jensen AW; Laack NN; Buckner JC; Schomberg PJ; Wetmore CJ; Brown PD Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1449-56. PubMed ID: 20045266 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group. Toner GC; Stockler MR; Boyer MJ; Jones M; Thomson DB; Harvey VJ; Olver IN; Dhillon H; McMullen A; Gebski VJ; Levi JA; Simes RJ Lancet; 2001 Mar; 357(9258):739-45. PubMed ID: 11253966 [TBL] [Abstract][Full Text] [Related]
19. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients. Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359 [TBL] [Abstract][Full Text] [Related]
20. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience. Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]